| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,732 |
8,277 |
$790K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,334 |
8,250 |
$576K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,536 |
4,886 |
$414K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,113 |
4,058 |
$327K |
| 90671 |
|
1,471 |
1,433 |
$138K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,486 |
1,466 |
$113K |
| 90698 |
|
2,985 |
2,900 |
$64K |
| 92552 |
|
2,057 |
2,026 |
$56K |
| 90670 |
|
2,349 |
2,289 |
$55K |
| 90680 |
|
2,507 |
2,433 |
$51K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,444 |
6,257 |
$49K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
597 |
580 |
$46K |
| 99188 |
|
1,528 |
1,516 |
$32K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14,526 |
8,395 |
$31K |
| 90716 |
|
1,151 |
1,130 |
$31K |
| 99381 |
|
358 |
320 |
$29K |
| 87428 |
|
821 |
798 |
$29K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,008 |
1,887 |
$26K |
| 90707 |
|
1,198 |
1,174 |
$25K |
| 90686 |
|
1,958 |
1,932 |
$24K |
| 90633 |
|
1,640 |
1,613 |
$24K |
| 90744 |
|
1,836 |
1,742 |
$24K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
157 |
153 |
$19K |
| 90461 |
|
5,446 |
5,012 |
$13K |
| 99174 |
|
2,476 |
2,439 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
944 |
445 |
$12K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
298 |
287 |
$11K |
| 90651 |
|
188 |
187 |
$11K |
| 99401 |
|
766 |
703 |
$10K |
| 81003 |
|
4,366 |
4,205 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
271 |
255 |
$9K |
| 87807 |
|
474 |
456 |
$6K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
680 |
669 |
$6K |
| 96161 |
|
2,691 |
2,553 |
$6K |
| 90381 |
|
34 |
34 |
$5K |
| 99383 |
|
42 |
42 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
330 |
272 |
$4K |
| 90734 |
|
121 |
114 |
$4K |
| 90656 |
|
223 |
222 |
$3K |
| 96127 |
|
700 |
679 |
$3K |
| 99173 |
|
1,322 |
1,301 |
$3K |
| 90700 |
|
190 |
187 |
$3K |
| 90619 |
|
59 |
59 |
$3K |
| 99000 |
|
1,184 |
1,154 |
$3K |
| 90696 |
|
171 |
167 |
$3K |
| 0071A |
|
60 |
60 |
$2K |
| 0072A |
|
52 |
50 |
$2K |
| 90648 |
|
170 |
166 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,020 |
999 |
$2K |
| 99215 |
Prolong outpt/office vis |
14 |
14 |
$2K |
| 90715 |
|
73 |
72 |
$1K |
| 99382 |
|
13 |
13 |
$1K |
| 90380 |
|
13 |
12 |
$1K |
| 36416 |
|
6,270 |
5,953 |
$846.20 |
| 96380 |
|
38 |
35 |
$589.30 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
34 |
28 |
$512.77 |
| 0001A |
|
12 |
12 |
$488.00 |
| 81002 |
|
151 |
139 |
$382.24 |
| 90660 |
|
16 |
16 |
$281.80 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14 |
14 |
$202.90 |
| 81000 |
|
57 |
54 |
$186.33 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
15 |
14 |
$66.24 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
16 |
16 |
$19.94 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15 |
15 |
$17.26 |
| 91300 |
|
111 |
95 |
$4.83 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
16 |
15 |
$0.35 |
| 91307 |
|
144 |
133 |
$0.00 |
| 99051 |
|
118 |
114 |
$0.00 |